These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19249197)

  • 1. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
    Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
    Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
    Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
    Wu SJ; Chen P; Jiang XN; Liu ZJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.
    Devanarayan V; Scholand MB; Hoidal J; Leppert MF; Crackower MA; O'Neill GP; Gervais FG
    COPD; 2010 Feb; 7(1):51-8. PubMed ID: 20214463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.
    Higashimoto Y; Yamagata Y; Taya S; Iwata T; Okada M; Ishiguchi T; Sato H; Itoh H
    Respirology; 2008 Jan; 13(1):128-33. PubMed ID: 18197923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
    Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
    Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
    Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
    Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
    Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
    Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.